Welcome to First China Pharmaceutical Group

Corporate Video (A Leader in The Pharmaceutical E-commerce Business)

First China Pharmaceutical Group, Inc. aims to become a major force in the high growth pharmaceutical distribution sector in China. As part of its business strategy, the Company has acquired the assets of Kun Ming Xin Yuan Tang Pharmacies Co. Ltd. (XYT) of Yunnan Province (pop. 45,710,000). Founded in 2002 and achieving profitability in 2003, XYT rapidly grew into a leading regional pharmaceutical distributor providing approximately 5,000 products to more than 4,700 pharmacies, hospitals and clinics in the People’s Republic of China. Securing a tremendous competitive advantage, it is one of a handful of companies in the province licensed to market and process pharmaceutical orders over the internet.  It is projected that an even broader product line will ensure customers the ability to order 80% to 90% of their product needs directly from the Company. In anticipation of this growth, the Company expects its business model to fully leverage the efficiencies of internet ordering and fulfillment through the rapid expansion of its capacity to approximately 30,000 products and to obtain further licensing that would enable customers direct access to the Company's proprietary logistics system and to enable payment processing over the internet.

Company Overview Keys to Success The Opportunity Investors
First China Pharmaceutical Group is a profitable provincial pharmaceutical distributor providing drug logistics and distribution in Yunnan Province, China.
Learn More...
First China Pharmaceutical Group is one of a few pharmaceutical distribution companies in Yunnan Province to be granted a "License of Internet Pharmacy Information Service" allowing online marketing and order processing.
Learn More...
The Chinese pharmaceutical market is growing more than 20% per year. China is on track to become the third-largest prescription drug market next year, with sales expected to grow by $40 billion by 2013 as the country improves its healthcare infrastructure.
Learn More...
First China Pharmaceutical Group is positioned to achieve near-term growth by dramatically expanding its product offerings, leveraging online ordering in order to bypass city and county distribution layers, increasing its customer base, and acquiring other established distributors.
Learn More...